Anjarium BioSciences

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Sonothera Therapeutics

This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

Borea Therapeutics

The company develops bio-conjugated viral vectors for gene therapy to treat patients with genetic or chronic diseases.

Ensoma

This company develops in vivo genomic medicines and vector delivery platforms to engineer blood and immune cells for patients with genetic diseases and cancer.

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.